D&P Medical Limited - Accounts to registrar (filleted) - small 23.2.5

REGISTERED NUMBER: 12022084 (England and Wales)

Financial Statements for the Year Ended 31 May 2023

for

D&P Medical Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr P Dhesi

D Karamchandani

REGISTERED OFFICE:

1C Amberside

Wood Lane

Hemel Hempstead

Hertfordshire

HP2 4TP

REGISTERED NUMBER:

12022084 (England and Wales)

ACCOUNTANTS:

Farrell & Co

1C Amberside

Wood Lane

Hemel Hempstead

Hertfordshire

HP2 4TP

FIXED ASSETS

Tangible assets

4

14,274

7,281

CURRENT ASSETS

Debtors

5

88,086

-

Cash at bank

24,306

44,853

112,392

44,853

CREDITORS

Amounts falling due within one year

6

114,424

40,833

NET CURRENT (LIABILITIES)/ASSETS

(2,032

)

4,020

TOTAL ASSETS LESS CURRENT LIABILITIES

12,242

11,301

PROVISIONS FOR LIABILITIES

1,025

780

NET ASSETS

11,217

10,521

CAPITAL AND RESERVES

Called up share capital

10,001

10,001

Retained earnings

7

1,216

520

11,217

10,521

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 February 2024 and were signed on its behalf by:

Dr P Dhesi - Director

1.	STATUTORY INFORMATION

D&P Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

20% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

£

COST

At 1 June 2022

10,948

Additions

10,562

At 31 May 2023

21,510

DEPRECIATION

At 1 June 2022

3,667

Charge for year

3,569

At 31 May 2023

7,236

NET BOOK VALUE

At 31 May 2023

14,274

At 31 May 2022

7,281

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.5.23

31.5.22

£

£

Trade debtors

88,086

-

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.5.23

31.5.22

£

£

Trade creditors

(1

)

1

Taxation and social security

9,213

10,516

Other creditors

105,212

30,316

114,424

40,833

7.

RESERVES

Retained

earnings

£

At 1 June 2022

520

Profit for the year

48,696

Dividends

(48,000

)

At 31 May 2023

1,216